Faculty: Global Regulatory Affairs in Drug Development Graduate Certificate

Next Term Application Deadline

April 01, 2023

Total Credits

Next Term Starts

May 08, 2023

Request More Information from an Enrollment Advisor

Step 1 of 2

Program of Interest*
Program requires the completion of an associate degree program. Have you earned an associate degree?*
- Yes (includes in-progress degree)
- No
Desired Start Date*

Name*
First Name Last Name
Email*
Country*

Country
*
State
ZIP
Hidden
*
Region Postal Code
Phone*
Phone*
Military Affiliated
Freely given consent from contact*
By submitting this form I accept the privacy policy and understand that University of Cincinnati may contact me via telephone, email, and/or text messages about educational programs using an automated technology.*
Comments
This field is for validation purposes and should be left unchanged.

Summer 2023 Information Session

Listen in as program director Dr. Pankaj Desai discusses the Drug Development and Pharmacogenomics programs, curriculums, work-life balance, and online school.

Learn From Nationally Renowned Faculty

The faculty staff for drug development have significant industrial experience and deep academic expertise. This unique combination of experience and expertise greatly adds to the training capabilities and strength of the program.

Watch Now

Training Faculty for Drug Development

Pankaj Desai, Ph.D. Professor and Chair of Pharmaceutical Sciences Division
Richard Schwen, Ph.D., DABT, RAC Adj. Professor & Vice-President of Regulatory Affairs, Ausio Pharmaceuticals
Jianfei Jeff Guo, Ph.D. Professor of Pharmacoeconnomics
William Seibel, Ph.D., Assistant Professor, Oncology Department, Cincinnati Children’s Hospital Medical Center
Daniel Shelly, Ph.D., MBA Adj. Professor, Director of Business Development, R&D Externalization, and Clinical Development at Albumedix
Nimita Dave, Ph.D., Senior Clinical Pharmacokineticist AbbVie Inc. Adj. Assistant Professor of Pharmaceutical Sciences
Brenna Carey, Ph.D., MSDD Adj. Assistant Professor & Project Manager at Cincinnati Children’s Hospital Medical Center
Cindy Rodenberg, Ph.D., Adj. Professor, Head of Statistics for Women’s Health at P&G
Niteen Bapat, Ph.D., Adj. Professor, Senior Scientist at P&G
Ruth Stevens, Ph.D., Adj. Professor, Chief Scientific Officer/Executive VP at Camargo Pharmaceutical Services
Christopher Anderson, Ph.D., Adj. Professor, Clinical Project Manager Director at IQVIA

Learn more about the faculty of James L. Winkle College of Pharmacy

No faculty found.

FAQs

How long does it take to complete the Global Regulatory Affairs in Drug Development Graduate Certificate?

The Global Regulatory Affairs in Drug Development Graduate Certificate is typically completed in 2 semesters or less than 1 year based on taking 2 courses per semester, which is the average pace.
What GPA do I need for the Global Regulatory Affairs in Drug Development Graduate Certificate?

For the Global Regulatory Affairs Drug Development Graduate Certificate, a grade-point average (GPA) of at least 3.00 or foreign equivalent is recommended.
What are the admission requirements for the Global Regulatory Affairs in Drug Development Graduate Certificate?
Requirements include:
- A U.S. bachelors degree from a regionally accredited college or university or an equivalent degree from a foreign country
- A grade-point average (GPA) of at least 3.00 or foreign equivalent
- Some experience in drug development or clinical research
- If English is not your native language, a Test of English as a Foreign Language (TOEFL) of at least 90 (internet-based) or 235 (computer-based) is required
- GRE is not required for the graduate certificate
Please visit the Admissions Requirements page for more information.